These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 9472620

  • 1. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes.
    Mikloska Z, Cunningham AL.
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():353-61. PubMed ID: 9472620
    [Abstract] [Full Text] [Related]

  • 2. Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-gamma.
    Mikloska Z, Kesson AM, Penfold ME, Cunningham AL.
    J Infect Dis; 1996 Jan; 173(1):7-17. PubMed ID: 8537685
    [Abstract] [Full Text] [Related]

  • 3. Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro.
    Cunningham AL, Noble JR.
    J Clin Invest; 1989 Feb; 83(2):490-6. PubMed ID: 2464000
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens.
    Tigges MA, Koelle D, Hartog K, Sekulovich RE, Corey L, Burke RL.
    J Virol; 1992 Mar; 66(3):1622-34. PubMed ID: 1310769
    [Abstract] [Full Text] [Related]

  • 6. Herpes simplex virus antigens directly activate NK cells via TLR2, thus facilitating their presentation to CD4 T lymphocytes.
    Kim M, Osborne NR, Zeng W, Donaghy H, McKinnon K, Jackson DC, Cunningham AL.
    J Immunol; 2012 May 01; 188(9):4158-70. PubMed ID: 22467654
    [Abstract] [Full Text] [Related]

  • 7. CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells.
    Koelle DM, Chen HB, Gavin MA, Wald A, Kwok WW, Corey L.
    J Immunol; 2001 Mar 15; 166(6):4049-58. PubMed ID: 11238653
    [Abstract] [Full Text] [Related]

  • 8. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M, Zarling JM.
    J Immunol; 1984 Jul 15; 133(1):422-7. PubMed ID: 6609990
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).
    Smith PM, Wolcott RM, Chervenak R, Jennings SR.
    Virology; 1994 Jul 15; 202(1):76-88. PubMed ID: 7912023
    [Abstract] [Full Text] [Related]

  • 12. Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein.
    Fu TM, Bonneau RH, Epler M, Tevethia MJ, Alam S, Verner K, Tevethia SS.
    Virology; 1996 Aug 01; 222(1):269-74. PubMed ID: 8806508
    [Abstract] [Full Text] [Related]

  • 13. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. III. Analysis of viral glycoproteins recognized by CTL clones by using recombinant herpes simplex viruses.
    Yasukawa M, Zarling JM.
    J Immunol; 1985 Apr 01; 134(4):2679-82. PubMed ID: 2579149
    [Abstract] [Full Text] [Related]

  • 14. Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection.
    McNally JM, Dempsey D, Wolcott RM, Chervenak R, Jennings SR.
    J Immunol; 1999 Jul 15; 163(2):675-81. PubMed ID: 10395657
    [Abstract] [Full Text] [Related]

  • 15. Herpes simplex virus glycoprotein D is recognized as antigen by CD4+ and CD8+ T lymphocytes from infected mice. Characterization of T cell clones.
    Johnson RM, Lancki DW, Fitch FW, Spear PG.
    J Immunol; 1990 Jul 15; 145(2):702-10. PubMed ID: 1973187
    [Abstract] [Full Text] [Related]

  • 16. Diminished secondary CTL response in draining lymph nodes on cutaneous challenge with herpes simplex virus.
    Jones CM, Cose SC, McNally JM, Jennings SR, Heath WR, Carbone FR.
    J Gen Virol; 2000 Feb 15; 81(Pt 2):407-14. PubMed ID: 10644839
    [Abstract] [Full Text] [Related]

  • 17. Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions.
    Koelle DM, Corey L, Burke RL, Eisenberg RJ, Cohen GH, Pichyangkura R, Triezenberg SJ.
    J Virol; 1994 May 15; 68(5):2803-10. PubMed ID: 7512152
    [Abstract] [Full Text] [Related]

  • 18. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.
    Arvin AM, Sharp M, Smith S, Koropchak CM, Diaz PS, Kinchington P, Ruyechan W, Hay J.
    J Immunol; 1991 Jan 01; 146(1):257-64. PubMed ID: 1670603
    [Abstract] [Full Text] [Related]

  • 19. Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes.
    Rosenthal KL, Smiley JR, South S, Johnson DC.
    J Virol; 1987 Aug 01; 61(8):2438-47. PubMed ID: 3037106
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of recognition of herpes simplex virus type 1-infected cells by natural killer cells.
    López-Guerrero JA, Alarcón B, Fresno M.
    J Gen Virol; 1988 Nov 01; 69 ( Pt 11)():2859-68. PubMed ID: 2846762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.